1.Dyslipidemia of atheromatous patients
Journal Ho Chi Minh Medical 2003;7(1):53-58
Study on 210 patients including 120 atheromatous patients, 90 non-atheromatous patients at Transfusion Blood Center in HCMC. Research results showed that: the lipid-lipoprotein disorders had colleration to atheromatous. It was statistical. Hypercholesterolemia 62.6%, hypertriglycerid 51.6%, hypo HDL-C 48.3%, hyper LDL-C 45.8%. The lipid-lipoprotein disorders and atheroscelrosis on the over forty year old patients were higher than the young patients but there was no difference between male and female
Dyslipidemias
;
Hyperlipidemia, Familial Combined
;
Disease
2.A case of acute hyperlipidemic pancreatitis in a patient suspected of familial combined hyperlipidemia.
Yeo Joo KIM ; Hyun Jun KIM ; Hyun Cheol KIM ; Sang Jin KIM ; Sang Heum PARK
Korean Journal of Medicine 2005;69(2):197-201
It is well recognized that there is an association between hyperlipidemia and pancreatitis. However, it is not so easy to define clearly whether lipid abnormalities are the cause or the result of pancreatitis. Generally, a serum level of more than 1,000 mg/dL of triglyceride is an identifiable risk factor of hyperlipidemic pancreatitis in patients with type I, IV, or V hyperlipidemia classified by Fredrick's criteria. The clinical course as well as the management of hyperlipidemic pancreatitis is not different from that of pancreatitis of other causes. A thorough family history of lipid abnormalities should be obtained and an attempt to identify secondary causes should be made. The mainstay of treatment includes dietary restriction of fat and lipid-lowering medications. In Korea, there have been reported several cases of hyperlipidemic pancreatitis but familial history of hyperlipidemia has never been identified. We experienced a case of acute type IV hyperlipidemic pancreatitis in a patient suspected of familial combined hyperlipidemia. So, we report this case with the review of related literature.
Humans
;
Hyperlipidemia, Familial Combined*
;
Hyperlipidemias
;
Korea
;
Pancreatitis*
;
Risk Factors
;
Triglycerides
3.Familial combined hyperlipidemia with tuberous and tendinous xanthomas: A case report.
Bautista Ma. Noemi Jane B. ; Gabriel Ma. Teresita G.
Journal of the Philippine Dermatological Society 2008;17(1):45-48
Familial combined hyperlipidemia, otherwise known as type IIb hyperlipoproteinemia or multiple lipoprotein-type hyperlipidemia is an inherited disorder of high serum cholesterol or high blood triglycerides. This disease is genetic and inherited, although the specific defective genes have not been identified. The person's cholesterol or triglyceride become elevated during the teenage years and continue to be high throughout life. The types of elevated lipoproteins may vary between affected family members. Its clinical manifestations include lipid disposition on the skin or tendons called "xanthomas" as well as on the arteries. People with this condition have an increased risk of cardiovascular disease so that it is essential to recognize early this type of disorder. We report a case of a 37 year-old male who presented with a bilateral yellowish to reddish nodules on the elbows, knees, ankles, malleoili, ventral aspect of both hands, fingers, feet and toes, metacarpophalangeal & proximal interphalangeal joints, back and buttocks of six years duration with an elevated levels.
Human ; Male ; Adult ; Ankle ; Arteries ; Buttocks ; Cardiovascular Diseases ; Cholesterol ; Hypercholesterolemia ; Hyperlipidemia, Familial Combined ; Hyperlipoproteinemias ; Lipoproteins ; Tendons ; Toes ; Triglycerides ; Xanthomatosis
4.One Family of Familial Combined hyperlipidemia Associated with Various Metabolic Abnormalities.
Kwan Woo LEE ; Sung Kyu LEE ; Yun Suk CHUNG ; Hyun Man KIM ; Yoon Jung KIM ; Eun Kyung HONG ; Bong Nam CHAE ; Ji Won PARK
Journal of Korean Society of Endocrinology 1999;14(2):418-424
Familial combined hyperlipidemia is one af the manogenic disorders frequently found in humans and is seen in 0.5~2% of the general populatian, accounting for at least 10% of persons with pemature atlmmcletusis. The distinguishing feature of familial combined hyperlipidemia, in camparison with other single-gene abnarmalities of lipoprotein metabolism, is that not all affected members have the same plasma lipid phenotype; some individuals have an elevation of cholesterol concentration alane(type IIa lipoprotein pattern), while some athers have an elevation of triglyceride concentration alone(type IV pattem), and still others have elevations of both values(type IIb pattem). In any one persan, the lipid phenotype can change as a result of dietary or drug treatment. Familial combined hyperlipidemia should be suspected in those subjects with moderate hypertriglyceridemia and/or moderate hypercholestaolemia (lipoprotein types IIa, Ilb, IV), especially when premature coronary heart disease is evident in the family histary. Low plasma HDL-cholesterol, obesity, insulin resistance and hyperuricemia are often . Family members affected by familial combined hyperlipidemia should be identified and be treated, since tbe condition is associated with premature caronary heart diasease. We have found one family of familial combined hyperlipidemia with one member(case 1) associated with insulin resistance, hyperuricemia and gout, and another member(case 2) associated with diabetes mellitus and infertiTity.
Cholesterol
;
Coronary Disease
;
Diabetes Mellitus
;
Gout
;
Heart
;
Humans
;
Hyperlipidemia, Familial Combined*
;
Hypertriglyceridemia
;
Hyperuricemia
;
Insulin Resistance
;
Lipoproteins
;
Metabolism
;
Obesity
;
Phenotype
;
Plasma
;
Triglycerides